387 related articles for article (PubMed ID: 24350845)
1. Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.
Schepetkin IA; Khlebnikov AI; Giovannoni MP; Kirpotina LN; Cilibrizzi A; Quinn MT
Curr Med Chem; 2014; 21(13):1478-504. PubMed ID: 24350845
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.
Kirpotina LN; Khlebnikov AI; Schepetkin IA; Ye RD; Rabiet MJ; Jutila MA; Quinn MT
Mol Pharmacol; 2010 Feb; 77(2):159-70. PubMed ID: 19903830
[TBL] [Abstract][Full Text] [Related]
3. 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Leopoldo M; Lucente E; Lacivita E; De Giorgio P; Quinn MT
Biochem Pharmacol; 2013 Feb; 85(3):404-16. PubMed ID: 23219934
[TBL] [Abstract][Full Text] [Related]
4. The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.
He HQ; Ye RD
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335409
[TBL] [Abstract][Full Text] [Related]
5. Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors.
Khlebnikov AI; Schepetkin IA; Quinn MT
Eur J Med Chem; 2010 Nov; 45(11):5406-19. PubMed ID: 20870313
[TBL] [Abstract][Full Text] [Related]
6. Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.
Giovannoni MP; Schepetkin IA; Cilibrizzi A; Crocetti L; Khlebnikov AI; Dahlgren C; Graziano A; Dal Piaz V; Kirpotina LN; Zerbinati S; Vergelli C; Quinn MT
Eur J Med Chem; 2013 Jun; 64():512-28. PubMed ID: 23685570
[TBL] [Abstract][Full Text] [Related]
7. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
[TBL] [Abstract][Full Text] [Related]
8. Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis.
Crocetti L; Vergelli C; Guerrini G; Cantini N; Kirpotina LN; Schepetkin IA; Quinn MT; Parisio C; Di Cesare Mannelli L; Ghelardini C; Giovannoni MP
Bioorg Chem; 2020 Jul; 100():103880. PubMed ID: 32388428
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.
Khlebnikov AI; Schepetkin IA; Kirpotina LN; Brive L; Dahlgren C; Jutila MA; Quinn MT
J Mol Model; 2012 Jun; 18(6):2831-43. PubMed ID: 22127612
[TBL] [Abstract][Full Text] [Related]
10. 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists.
Vergelli C; Schepetkin IA; Ciciani G; Cilibrizzi A; Crocetti L; Giovannoni MP; Guerrini G; Iacovone A; Kirpotina LN; Khlebnikov AI; Ye RD; Quinn MT
Bioorg Med Chem; 2016 Jun; 24(11):2530-2543. PubMed ID: 27134116
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists.
Vergelli C; Schepetkin IA; Ciciani G; Cilibrizzi A; Crocetti L; Giovannoni MP; Guerrini G; Iacovone A; Kirpotina LN; Ye RD; Quinn MT
Drug Dev Res; 2017 Feb; 78(1):49-62. PubMed ID: 27859446
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
[TBL] [Abstract][Full Text] [Related]
13. Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes.
Stepniewski TM; Filipek S
Bioorg Med Chem; 2015 Jul; 23(14):4072-81. PubMed ID: 25882522
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists.
Vergelli C; Khlebnikov AI; Crocetti L; Guerrini G; Cantini N; Kirpotina LN; Schepetkin IA; Cilibrizzi A; Quinn MT; Rossi P; Paoli P; Giovannoni MP
Chem Biol Drug Des; 2021 Oct; 98(4):582-603. PubMed ID: 34148303
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Evolution of Bacterial Ligand Recognition by Formyl Peptide Receptors.
Paterson NM; Al-Zubieri H; Ragona J; Kohler KM; Tirado J; Geisbrecht BV; Barber MF
Genome Biol Evol; 2023 Oct; 15(10):. PubMed ID: 37776517
[TBL] [Abstract][Full Text] [Related]
16. Formyl Peptide Receptors in Mice and Men: Similarities and Differences in Recognition of Conventional Ligands and Modulating Lipopeptides.
Winther M; Dahlgren C; Forsman H
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):191-198. PubMed ID: 28881079
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.
Zhuang Y; Wang L; Guo J; Sun D; Wang Y; Liu W; Xu HE; Zhang C
Nat Commun; 2022 Feb; 13(1):1054. PubMed ID: 35217703
[TBL] [Abstract][Full Text] [Related]
18. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
[TBL] [Abstract][Full Text] [Related]
19. Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver.
Lee C; Han J; Jung Y
Exp Mol Med; 2023 Feb; 55(2):325-332. PubMed ID: 36750693
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.
He HQ; Troksa EL; Caltabiano G; Pardo L; Ye RD
J Biol Chem; 2014 Jan; 289(4):2295-306. PubMed ID: 24285541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
